5-S-cysteinyldopamine

Subscribe to Selected New Research on 5-S-cysteinyldopamine

5 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Also Known As:

5-SCDA; L-Cysteine, S-(5-(2-aminoethyl)-2,3-dihydroxyphenyl)-

Bio-Agent Context: Research Results

Organic Chemicals: 40

Amines: 1233

Catecholamines: 5627

Dopamine: 11611

5-S-cysteinyldopamine: 5

Biogenic Amines: 657

Biogenic Monoamines: 24

Catecholamines: 5627

Dopamine: 11611

5-S-cysteinyldopamine: 5

Experts

1.	Shen, X M: 1 article (01/2000)
2.	Dryhurst, G: 1 article (01/2000)
3.	Li, H: 1 article (01/2000)

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 12/01/2001 - "Recent results from in vitro and in vivo models have suggested that some products from mercapturic acid pathway (MAP) metabolism of oxidized dopamine (DA) may contribute to dopaminergic neurodegeneration, and that at least one product of this pathway, 5-S-cysteinyldopamine (Cys-DA), is elevated in patients with advanced Parkinson's disease (PD)" 01/01/2000 - "A characteristic change in the substantia nigra of Parkinson's disease patients is an apparent accelerated rate of dopamine oxidation as evidenced by an increased 5-S-cysteinyldopamine (5-S-CyS-DA) to dopamine ratio" 01/01/2000 - "Oxidative metabolites of 5-S-cysteinyldopamine inhibit the alpha-ketoglutarate dehydrogenase complex: possible relevance to the pathogenesis of Parkinson's disease." 11/01/2001 - "Recent results have suggested that some products of mercapturic acid pathway (MAP) metabolism of oxidized dopamine (DA) may contribute to mesostriatal dopaminergic neurodegeneration, and that at least one product, 5-S-cysteinyldopamine (Cys-DA), is elevated in patients with advanced Parkinson's disease (PD) who have been treated with L-DOPA" 01/01/1996 - "High-performance liquid chromatography with electrochemical detection has been employed to analyze ultrafiltrates of cerebrospinal fluid of Parkinson's Disease (PD) patients and age-matched controls for the dopamine (DA) metabolites homovanillic acid (HVA) and 5-S-cysteinyldopamine (5-S-CyS-DA)" Get all the results and reference details, order at left...
2.	Ascorbic Acid Deficiency (Vitamin C Deficiency) 02/01/1991 - "Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum." Get all the results and reference details, order at left...
2 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Dopamine (Intropin)
2.	Levodopa (L Dopa)
3.	Ketoglutarate Dehydrogenase Complex (Oxoglutarate Dehydrogenase)
4.	Homovanillic Acid
4 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>